![E. Kelley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
E. Kelley
Directeur Technique/Scientifique/R&D chez
CNS PHARMACEUTICALS, INC.
Fortune : 14 203 $ au 31/08/2026
Profil
E.
Lynne Kelley is Chief Medical Officer at CNS Pharmaceuticals, Inc. since 2026 and Chief Executive & Medical Officer at Signalexis, Inc. Former roles include Chief Medical Officer at Tissium, Inc. from 2024 to 2026, Chief Medical Officer at X4 Pharmaceuticals, Inc. from 2019 to 2020, Chief Medical Officer at Histogenics Corp.
from 2018 to 2019, Vice President-Medical Affairs at Becton, Dickinson & Co. from 2011 to 2016, Medical Director at Kimberly-Clark Corp.
from 2007 to 2010, Medical Director at Boston Scientific Corp.
from 2005 to 2007, Assistant Professor at Yale University from 2003 to 2005, and Chief Medical Officer at Senseonics Holdings, Inc. Education includes undergraduate studies at Boston University and a doctorate from Dartmouth Medical School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/08/2026 | 2 375 ( 0,16 % ) | 14 203 $ | 31/08/2026 |
Postes actifs de E. Kelley
| Sociétés | Poste | Début |
|---|---|---|
| CNS PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 02/03/2026 |
Anciens postes connus de E. Kelley
| Sociétés | Poste | Fin |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 03/04/2020 |
| OCUGEN, INC. | Directeur Technique/Scientifique/R&D | 23/01/2019 |
| BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | 01/01/2016 |
| KIMBERLY-CLARK CORPORATION | Directeur Technique/Scientifique/R&D | 01/12/2010 |
Formation de E. Kelley
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
83
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Becton, Dickinson & Co.
 Becton, Dickinson & Co. Medical SpecialtiesHealth Technology Manufactures and sells medical supplies, devices, laboratory equipment & diagnostic products | Health Technology |
Kimberly-Clark Corp.
 Kimberly-Clark Corp. Household/Personal CareConsumer Non-Durables Manufactures paper based products and provides cleaning solutions | Consumer Non-Durables |
Boston Scientific Corp.
 Boston Scientific Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiology, endoscopy, peripheral intervention, urology & neuromodulation equipment | Health Technology |
Histogenics Corp.
 Histogenics Corp. BiotechnologyHealth Technology Develops and commercializes regenerative medicine | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dartmouth Medical School
 Dartmouth Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Senseonics Holdings, Inc.
 Senseonics Holdings, Inc. Electronic ComponentsElectronic Technology Develops transformative glucose monitoring products | Electronic Technology |
CNS Pharmaceuticals, Inc.
 CNS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical drugs | Health Technology |
X4 Pharmaceuticals, Inc.
 X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
